Athersys to Announce First Quarter Financial Results on May 6
April 29 2022 - 9:00AM
Business Wire
Quarterly Conference Call to be Held Following
Announcement of Phase 2/3 TREASURE Data in May
Athersys, Inc. (Nasdaq: ATHX) today announced that it will
release its first quarter 2022 financial results on Friday, May 6,
2022, at 8:00 a.m. EDT. In anticipation of the announcement of
topline data from Athersys’ partner, HEALIOS K.K., for its Phase
2/3 TREASURE study evaluating MultiStem® (invimestrocel, HLCM051)
for the treatment of ischemic stroke in May, Athersys will host its
next investor conference call after the data are released. Athersys
will share the call details in its own news release reporting the
data.
About Athersys
Athersys is a biotechnology company engaged in the discovery and
development of therapeutic product candidates designed to extend
and enhance the quality of human life. The Company is developing
its MultiStem® cell therapy product, a patented, adult-derived
"off-the-shelf" stem cell product, initially for disease
indications in the neurological, inflammatory and immune,
cardiovascular, and other critical care indications and has several
ongoing clinical trials evaluating this potential regenerative
medicine product. Athersys has forged strategic partnerships and a
broad network of collaborations to further advance MultiStem cell
therapy toward commercialization. Investors and others should note
that we may post information about the Company on our website at
www.athersys.com and/or on our accounts on Twitter, Facebook,
LinkedIn or other social media platforms. It is possible that the
postings could include information deemed to be material
information. Therefore, we encourage investors, the media and
others interested in the Company to review the information we post
on our website at www.athersys.com and on our social media
accounts. Follow Athersys on Twitter at www.twitter.com/athersys.
Information that we may post about the Company on our website
and/or on our accounts on Twitter, Facebook, LinkedIn or other
social media platforms may contain forward-looking statements
within the meaning of the Private Securities Litigation Reform Act
of 1995 that involve risks and uncertainties. You should not place
undue reliance on forward-looking statements contained on our
website and/or on our accounts on Twitter, Facebook, LinkedIn or
other social media platforms, and we undertake no obligation to
publicly update forward-looking statements, whether as a result of
new information, future events or otherwise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220429005090/en/
Ivor Macleod Chief Financial Officer Tel: (216) 431-9900
ir@athersys.com Karen Hunady Director of Corporate Communications
and Investor Relations Tel: (216) 431-9900 khunady@athersys.com
David Schull Russo Partners, LLC Tel: (212) 845-4271 or (858)
717-2310 David.schull@russopartnersllc.com
Peter Vozzo ICR Westwicke Tel: (443) 213-0505
peter.vozzo@westwicke.com
Athersys (NASDAQ:ATHX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Athersys (NASDAQ:ATHX)
Historical Stock Chart
From Apr 2023 to Apr 2024